Skip to main content
logo
Xvivo Perfusion AB (publ) (XVIPF)
OTCMKTS · Delayed Price · Currency is USD
23.52
+0.30 (1.26%)
Feb 11, 2026, 9:30 AM EST

Xvivo Perfusion AB Revenue

In the year 2025, Xvivo Perfusion AB had annual revenue of 812.17M SEK, down -1.25%. Xvivo Perfusion AB had revenue of 226.14M in the quarter ending December 31, 2025, a decrease of -0.62%.

Revenue
812.17M SEK
Revenue Growth
-1.25%
P/S Ratio
7.24
Revenue / Employee
4.10M SEK
Employees
198
Market Cap
638.12M USD

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025812.17M-10.25M-1.25%
Dec 31, 2024822.42M224.87M37.63%
Dec 31, 2023597.54M182.25M43.88%
Dec 31, 2022415.29M156.91M60.73%
Dec 31, 2021258.39M78.53M43.66%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Zomedica29.45M
OpGen9.00M
Tian'an Technology Group2.12M
PetVivo Holdings1.41M
Positron486.45K
Guided Therapeutics178.00K
CS Diagnostics98.73K
Vivos48.62K
Revenue Rankings

Xvivo Perfusion AB News

More News